Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Product › Details

tepotinib (MSC2156119J)

Products Next higher product group c-MET inhibitor
Period Status 2016-09-28 development p2 existent
Organisation Organisation Merck (DE) (Group)
Document Source Merck KGaA. (9/28/16). "Press Release: Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016 [Not for U.S. and UK media]". Darmstadt.

Record changed: 2019-11-27


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for cancer drug

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top